NIAID Banner Logo Image

HIV Citations List: April, 2017

Literature Citations

1. Synthesis and Biological Evaluation of New Dipyridylpteridines, Lumazines, and Related Analogues. Abbas, Z.A.A., N.M.J. Abu-Mejdad, Z.W. Atwan, and N.A. Al-Masoudi. Journal of Heterocyclic Chemistry, 2017. 54(2): p. 895-903. ISI[000397563000009].
[WOS]. HIV_04_2017.


2. Sonication-assisted Synthesis of (E)-2-Methyl-but-2-enyl Nucleoside Phosphonate Prodrugs. Bessieres, M., O. Sari, V. Roy, D. Warszycki, A.J. Bojarski, S.P. Nolan, R. Snoeck, G. Andrei, R.F. Schinazi, and L.A. Agrofoglio. ChemistrySelect, 2016. 1(12): p. 3108-3113. ISI[000395421300019].
[WOS]. HIV_04_2017.


3. Chimeric Peptide-mediated siRNA Transduction to Inhibit HIV-1 Infection. Bivalkar-Mehla, S., R. Mehla, and A. Chauhan. Journal of Drug Targeting, 2017. 25(4): p. 307-319. PMID[27800697].
[PubMed]. HIV_04_2017.


4. Lack of ADCC Breadth of Human Nonneutralizing anti-HIV-1 Antibodies. Bruel, T., F. Guivel-Benhassine, V. Lorin, H. Lortat-Jacob, F. Baleux, K. Bourdic, N. Noel, O. Lambotte, H. Mouquet, and O. Schwartz. Journal of Virology, 2017. 91(8). PMID[28122982]. PMCID[PMC5375671].
[PubMed]. HIV_04_2017.


5. Chelation Motifs Affecting Metal-dependent Viral Enzymes: N'-Acylhydrazone Ligands as Dual Target Inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H Domain. Carcelli, M., D. Rogolino, A. Gatti, N. Pala, A. Corona, A. Caredda, E. Tramontano, C. Pannecouque, L. Naesens, and F. Esposito. Frontiers in Microbiology, 2017. 8(440): 10pp. PMID[28373864]. PMCID[PMC5357622].
[PubMed]. HIV_04_2017.


6. Broad and Potent Cross Clade Neutralizing Antibodies with Multiple Specificities in the Plasma of HIV-1 Subtype C Infected Individuals. Cheedarla, N., K.L. Precilla, H. Babu, K.K.V. Vijayan, M. Ashokkumar, P. Chandrasekaran, N. Kailasam, J.C. Sundaramurthi, S. Swaminathan, V. Buddolla, S.K. Vaniambadi, V.D. Ramanathan, and L.E. Hanna. Scientific Reports, 2017. 7(46557): 13pp. PMID[28436427]. PMCID[PMC5402285].
[PubMed]. HIV_04_2017.


7. Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120. Curreli, F., Y.D. Kwon, D.S. Belov, R.R. Ramesh, A.V. Kurkin, A. Altieri, P.D. Kwong, and A.K. Debnath. Journal of Medicinal Chemistry, 2017. 60(7): p. 3124-3153. PMID[28266845].
[PubMed]. HIV_04_2017.


8. Synthesis of beta-L-2'-Fluoro-3'-thiacytidine (F-3TC) Stereoisomers: Toward a New Class of Oxathiolanyl Nucleosides? D'Alonzo, D., M. De Fenza, G. Palumbo, V. Romanucci, A. Zarrelli, G. Di Fabio, and A. Guaragna. Synthesis, 2017. 49(5): p. 998-1008. ISI[000398093000011].
[WOS]. HIV_04_2017.


9. Site-specific Polymer Attachment to HR2 Peptide Fusion Inhibitors against HIV-1 Decreases Binding Association Rates and Dissociation Rates Rather Than Binding Affinity. Danial, M., A.N. Stauffer, F.R. Wurm, M.J. Root, and H.A. Klok. Bioconjugate Chemistry, 2017. 28(3): p. 701-712. PMID[27737540]. PMCID[PMC5352488].
[PubMed]. HIV_04_2017.


10. Dihydropyrimidinone-isatin Hybrids as Novel Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. Devale, T.L., J. Parikh, P. Miniyar, P. Sharma, B. Shrivastava, and P. Murumkar. Bioorganic Chemistry, 2017. 70: p. 256-266. PMID[28160944].
[PubMed]. HIV_04_2017.


11. Inhibition of HIV-1 Protease and Plasmodium falciparum by a Modified Digold chloroquine Derivative. Gama, N., K. Kumar, J. Reader, B. Gordhan, L.M. Birkholtz, B. Kana, J. Darkwa, and D. Meyer. Journal of the International AIDS Society, 2016. 19(P028): p. 37-38. ISI[000395394900071].
[WOS]. HIV_04_2017.


12. Screening and Functional Profiling of Small-molecule HIV-1 Entry and Fusion Inhibitors. Giroud, C., Y.H. Du, M. Marin, Q. Min, N.T. Jui, H.A. Fu, and G.B. Melikyan. Assay and Drug Development Technologies, 2017. 15(2): p. 53-63. PMID[28322598]. PMCID[PMC5367911].
[PubMed]. HIV_04_2017.


13. Lipid Raft-like Liposomes Used for Targeted Delivery of a Chimeric Entry-inhibitor Peptide with anti-HIV-1 Activity. Gomara, M.J., I. Perez-Pomeda, J.M. Gatell, V. Sanchez-Merino, E. Yuste, and I. Haro. Nanomedicine: Nanotechnology, Biology and Medicine, 2017. 13(2): p. 601-609. PMID[27565689].
[PubMed]. HIV_04_2017.


14. P-D9 A Novel Small Molecule Inhibitor of HIV-1 Entry. Heredia, A., O. Latinovic, and F. Barbault. Journal of Acquired Immune Deficiency Syndromes, 2016. 71: p. 95-95. ISI[000398396800119].
[WOS]. HIV_04_2017.


15. Elimination of HIV-1 Latently Infected Cells by PKC Agonist Gnidimacrin Alone and in Combination with a Histone Deacetylase Inhibitor. Huang, L., W. Lai, L. Zhu, and C.H. Chen. Journal of the International AIDS Society, 2016. 19(THAA0106LB): p. 72. ISI[000395394300139].
[WOS]. HIV_04_2017.


16. HIV-1 Combinectin GSK3732394: A Long-acting Inhibitor with Multiple Modes of Action. Krystal, M., D. Wensel, Y.N. Sun, J. Davis, T. McDonagh, Z.F. Li, S.R. Zhang, M. Soars, and M. Cockett. Journal of the International AIDS Society, 2016. 19(P022): p. 34. ISI[000395394900065].
[WOS]. HIV_04_2017.


17. Triple Drug Combination of Zidovudine, Efavirenz and Lamivudine Loaded Lactoferrin Nanoparticles: An Effective Nano First-line Regimen for HIV Therapy. Kumar, P., Y.S. Lakshmi, and A.K. Kondapi. Pharmaceutical Research, 2017. 34(2): p. 257-268. PMID[27928647].
[PubMed]. HIV_04_2017.


18. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-cell Transmission of HIV-1 with Transmitted Founder Envs. Li, H., C. Zony, P. Chen, and B.K. Chen. Journal of Virology, 2017. 91(9): e02425-16. PMID[28148796]. PMCID[PMC5391450].
[PubMed]. HIV_04_2017.


19. A Novel Polysaccharide with Antioxidant, HIV Protease Inhibiting and HIV Integrase Inhibiting Activities from Fomitiporia punctata (P. Karst.) Murrill (Basidiomycota, Hymenochaetales). Liu, F., Y. Wang, K. Zhang, Y. Wang, R. Zhou, Y. Zeng, Y. Han, and T.B. Ng. International Journal of Biological Macromolecules, 2017. 97: p. 339-347. PMID[28089931].
[PubMed]. HIV_04_2017.


20. Structural Modifications of Diarylpyrimidines (DAPYs) as HIV-1 NNRTIs: Synthesis, anti-HIV Activities and SAR. Lu, H.H., P. Xue, Y.Y. Zhu, X.L. Ju, X.J. Zheng, X. Zhang, T. Xiao, C. Pannecouque, T.T. Li, and S.X. Gu. Bioorganic & Medicinal Chemistry, 2017. 25(8): p. 2491-2497. PMID[28314514].
[PubMed]. HIV_04_2017.


21. Enantioselective Synthesis of 4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) via Enzymatic Desymmetrization. McLaughlin, M., J. Kong, K.M. Belyk, B. Chen, A.W. Gibson, S.P. Keen, D.R. Lieberman, E.M. Milczek, J.C. Moore, D. Murray, F. Peng, J. Qi, R.A. Reamer, Z.J. Song, L.S. Tan, L. Wang, and M.J. Williams. Organic Letters, 2017. 19(4): p. 926-929. PMID[28165251].
[PubMed]. HIV_04_2017.


22. Synthesis of Novel HIV-1 Protease Inhibitors via Diastereoselective Henry Reaction with Nitrocyclopropane. Mitchell, M.L., L.H. Xu, Z.E. Newby, and M.C. Desai. Tetrahedron Letters, 2017. 58(12): p. 1123-1126. ISI[000397376600010].
[WOS]. HIV_04_2017.


23. Synthesis of 3-Oxoesters and Functional Derivatives of Pyrimidin-4(3H)-one Based on 1-(2,6-Dihalophenyl)cyclopropan-1-carboxylic acids. Novakov, I.A., A.S. Yablokov, M.B. Navrotskii, A.S. Mkrtchyan, A.A. Vernigora, A.S. Babushkin, V.V. Kachala, and E.A. Ruchko. Russian Journal of General Chemistry, 2017. 87(2): p. 224-230. ISI[000399167900012].
[WOS]. HIV_04_2017.


24. The Small-molecule 3G11 Inhibits HIV-1 Reverse Transcription. Opp, S., T. Fricke, C. Shepard, D. Kovalskyy, A. Bhattacharya, F. Herkules, D.N. Ivanov, B. Kim, J. Valle-Casuso, and F. Diaz-Griffero. Chemical Biology and Drug Design, 2017. 89(4): p. 608-618. PMID[27748043]. PMCID[PMC5378662].
[PubMed]. HIV_04_2017.


25. Synthesis of Peptide-functionalized Poly(bis-sulfone) Copolymers Regulating HIV-1 Entry and Cancer Stem Cell Migration. Riegger, A., C.J. Cheni, O. Zirafi, N. Daiss, D. Mukherji, K. Walter, Y. Tokura, B. Stockle, K. Kremer, F. Kirchhoff, D.Y.W. Ng, P.C. Hermann, J. Munch, and T. Weil. ACS Macro Letters, 2017. 6(3): p. 241-246. ISI[000397478700011].
[WOS]. HIV_04_2017.


26. Quantitative Structure-Activity Relationship and Docking Studies on a Series of Oxadiazole and Triazole Substituted Naphthyridines as HIV-1 Integrase Inhibitors. Shaik, B., V. Agrawal, S.P. Gupta, and U. Menon. Letters in Drug Design & Discovery, 2017. 14(1): p. 10-27. ISI[000395672000003].
[WOS]. HIV_04_2017.


27. Modulation of the Splicing Regulatory Function of SRSF10 by a Novel Compound That Impairs HIV-1 Replication. Shkreta, L., M. Blanchette, J. Toutant, E. Wilhelm, B. Bell, B.A. Story, A. Balachandran, A. Cochrane, P.K. Cheung, P.R. Harrigan, D.S. Grierson, and B. Chabot. Nucleic Acids Research, 2017. 45(7): p. 4051-4067. PMID[27928057]. PMCID[PMC5397194].
[PubMed]. HIV_04_2017.


28. Natural Product-inspired Esters and Amides of Ferulic and Caffeic acid as Dual Inhibitors of HIV-1 Reverse Transcriptase. Sonar, V.P., A. Corona, S. Distinto, E. Maccioni, R. Meleddu, B. Fois, C. Floris, N.V. Malpure, S. Alcaro, E. Tramontano, and F. Cottiglia. European Journal of Medicinal Chemistry, 2017. 130: p. 248-260. PMID[28254698].
[PubMed]. HIV_04_2017.


29. A Novel HIV-1 gp41 Tripartite Model for Rational Design of HIV-1 Fusion Inhibitors with Improved Antiviral Activity. Su, S., Q. Wang, W. Xu, F. Yu, C. Hua, Y. Zhu, S. Jiang, and L. Lu. AIDS, 2017. 31(7): p. 885-894. PMID[28121713].
[PubMed]. HIV_04_2017.


30. Evaluation of 4-Thiazolidinone Derivatives as Potential Reverse Transcriptase Inhibitors against HIV-1 Drug Resistant Strains. Suryawanshi, R., S. Jadhav, N. Makwana, D. Desai, D. Chaturbhuj, A. Sonawani, S. Idicula-Thomas, V. Murugesan, S.B. Katti, S. Tripathy, R. Paranjape, and S. Kulkarni. Bioorganic Chemistry, 2017. 71: p. 211-218. PMID[28236450].
[PubMed]. HIV_04_2017.


31. Inhibition of HIV-1 Maturation via Small-molecule Targeting of the Amino-terminal Domain in the Viral Capsid Protein. Wang, W., J. Zhou, U.D. Halambage, K.A. Jurado, A.V. Jamin, Y. Wang, A.N. Engelman, and C. Aiken. Journal of Virology, 2017. 91(9). PMID[28202766]. PMCID[PMC5391466].
[PubMed]. HIV_04_2017.


32. The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity. Wang, Y., Q. Pan, S. Ding, Z. Wang, J. Yu, A. Finzi, S.L. Liu, and C. Liang. Journal of Virology, 2017. 91(7). PMID[28100616]. PMCID[PMC5355610].
[PubMed]. HIV_04_2017.


33. Antiviral and Cytostatic Evaluation of 5-(1-Halo-2-sulfonylvinyl)- and 5-(2-Furyl)uracil Nucleosides. Wen, Z., S.H. Suzol, J. Peng, Y. Liang, R. Snoeck, G. Andrei, S. Liekens, and S.F. Wnuk. Archiv der Pharmazie, 2017. 350(3-4): e1700023. PMID[28304114].
[PubMed]. HIV_04_2017.


34. Isolation and anti-HIV-1 Integrase Activity of Lentzeosides A-F from Extremotolerant Lentzea sp. H45, a Strain Isolated from a High-altitude Atacama Desert Soil. Wichner, D., H. Idris, W.E. Houssen, A.R. McEwan, A.T. Bull, J.A. Asenjo, M. Goodfellow, M. Jaspars, R. Ebel, and M.E. Rateb. Journal of Antibiotics, 2017. 70(4): p. 448-453. PMID[27353167].
[PubMed]. HIV_04_2017.


35. Design and Synthesis of Hybrids of Diarylpyrimidines and Diketo Acids as HIV-1 Inhibitors. Xue, P., H.H. Lu, Y.Y. Zhu, X.L. Ju, C. Pannecouque, X.J. Zheng, G.Y. Liu, X.L. Zhang, and S.X. Gu. Bioorganic & Medicinal Chemistry Letters, 2017. 27(8): p. 1640-1643. PMID[28314598].
[PubMed]. HIV_04_2017.


36. New Phenylpropanoid and 6H-diBenzo[b,d]pyran-6-one Derivatives from the Stems of Dasymaschalon rostratum. Yu, Z.X., Z.G. Niu, X.B. Li, C.J. Zheng, X.M. Song, G.Y. Chen, X.P. Song, C.R. Han, and S.X. Wu. Fitoterapia, 2017. 118: p. 27-31. PMID[28229940].
[PubMed]. HIV_04_2017.


37. Anti-HIV Diphyllin glycosides from Justicia gendarussa. Zhang, H.J., E. Rumschlag-Booms, Y.F. Guan, K.L. Liu, D.Y. Wang, W.F. Li, V.H. Nguyen, N.M. Cuong, D.D. Soejarto, H.H. Fong, and L. Rong. Phytochemistry, 2017. 136: p. 94-100. PMID[28110956].
[PubMed]. HIV_04_2017.


38. Total Syntheses of Sesterterpenoid Ansellones A and B, and Phorbadione. Zhang, W., H. Yao, J. Yu, Z. Zhang, and R. Tong. Angewandte Chemie, 2017. 56(17): p. 4787-4791. PMID[28371092].
[PubMed]. HIV_04_2017.


39. Identification of SERINC5-001 as the Predominant Spliced Isoform for HIV-1 Restriction. Zhang, X., T. Zhou, J. Yang, Y. Lin, J. Shi, X. Zhang, D.A. Frabutt, X. Zeng, S. Li, P.J. Venta, and Y.H. Zheng. Journal of Virology, 2017. 91(10): e00137-17. PMID[28275190].
[PubMed]. HIV_04_2017.

Patent Citations

40. Preparation of Triterpene Compounds with HIV Maturation Inhibitory Activity. Johns, B.A. Patent. 2017. 2016-IB55676 2017051355: 110pp.
[Patent]. HIV_04_2017.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2021